A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Clinical trial NCT06843967 · RECRUITING

Trial details

NCT number: NCT06843967
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Well Differentiated Liposarcoma Dedifferentiated Liposarcoma Liposarcoma Myxoid Liposarcoma Round Cell Liposarcoma Myxoid Pleomorphic Liposarcoma Pleomorphic Liposarcoma Unresectable Liposarcoma Unresectable Dedifferentiated Liposarcoma

Start date: 2025-02-19
Primary completion: 2028-08-19
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.